Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
Conference Series LLC LTD in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , Retroviruses, Flu, HIV and Epidemiology
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.
Conference Series LLC LTD
Conference Series LLC LTD, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.
Conference Series LLC LTD are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.
The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.
Euro Infectious Diseases 2019: 11th Euro-Global Conference on Infectious Diseases focuses on Improving the Implementation and Efficacy of Solutions to Control Infectious Diseases. It is with better understanding of treatment; one can know the right procedure to treat the infections. More research on infectious diseases deals with identifying and responding to affected area and its effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction of inhibiting the effect and identify the properties of Infections causing organisms. Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. The ‘Best Poster Award’ is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase. The global market for Infectious Diseases products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the microorganisms by enhancing treatments through research in Immunology and Biotechnology.
Viral Diseases, Bacterial Diseases, and Fungal Diseases, Dermatology and Infectious Diseases, Neurological Diseases, Pharmacology and Therapeutics, HIV and AIDS, Ophthalmology and Visual Sciences, Public health, Vaccines, Respiratory Diseases, Paediatric Infectious Diseases and Obstetrics and Gynaecology
Infection Prevention 2019: 15th World Congress on Infection Prevention and Control to be scheduled during October 21-22, 2019 in Zurich, Switzerland. Infection Prevention 2019 conference which will discuss the novel Research topics and therapeutic aspects developed for infection control and prevention, where you will be sure to have knowledge with scholars and experts from around the world for the paradigm of the infection control and its cure. It will be a unique opportunity for high quality scientific program with session lectures, Keynote Talks, symposia, workshops, poster presentations, Exhibition and different programs for participants from throughout the world. Also, as per a research published in NCBI, 40% to 60% of hospital infections were estimated to be of surgical sites. These prolonged stays are predicted to be a significant contributor to the overall costs, incurred during the hospitalization period, thus, raising the clinical urgency for adoption of infection prevention measures. Approximately 4.0 million deaths occur every year due to ARDs. The aforementioned statistics exemplify the high need for stringent prevention and control.
Infection Prevention Control and Cure, Infection Control Procedures, Immunizations, Disinfection and Sterilization, Hospital Infections and Epidemiology, Nosocomial Infections & Control, Infection Control in Critical Care, Emerging and Re-Emerging Infections, Ebola Infection & Control, Microbial Pathogenesis and Virulence, Infection Control in Dialysis, Blood Borne and Exposure Control, Antimicrobial Chemo Therapy, Infection Control in Nursing, Infection Associated with Intra Vascular Therapy, Personal Hygiene Practices, Respiratory Tract Infection Therapy, Preventing Gastrointestinal Infection, Infection Control in Clinical Practice, Infection Control Risk Assessment, Plant Pathology and Diseases Control, Infection Control for Veterinary Practices, Infections During Pregnancy, Infection Control in Dental Diseases, Infection Prevention and Control Guidelines, Patient Risk Factors, Infection & Control Training Practices, Infection Control in Emergency
Major Companies Related to Infectious Diseases